Pfizer ' s COVID-19 Vaccine 95% Effective in Final Phase 3 Results Pfizer ' s COVID-19 Vaccine 95% Effective in Final Phase 3 Results
The race for approval of a COVID-19 vaccine accelerates with completion of all safety and efficacy data required for an FDA emergency use authorization.Medscape Medical News
Source: Medscape Pulmonary Medicine Headlines - Category: Respiratory Medicine Tags: Infectious Diseases News Alert Source Type: news
More News: COVID-19 | Emergency Medicine | Infectious Diseases | Pfizer | Respiratory Medicine | Vaccines